BlackRock’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $62 | Sell |
|
|||||
|
2023
Q3 | $383 | Sell |
|
|||||
|
2023
Q2 | $868 | Sell |
|
|||||
|
2023
Q1 | $14.1K | Buy |
|
|||||
|
2022
Q4 | $14.1K | Buy |
|
|||||
|
2022
Q3 | $29K | Sell |
|
|||||
|
2022
Q2 | $80K | Sell |
|
|||||
|
2022
Q1 | $141K | Sell |
|
|||||
|
2021
Q4 | $220K | Sell |
|
|||||
|
2021
Q3 | $295K | Sell |
|
|||||
|
2021
Q2 | $416K | Sell |
|
|||||
|
2021
Q1 | $6.87M | Buy |
|
|||||
|
2020
Q4 | $6.5M | Buy |
|
|||||
|
2020
Q3 | $6.88M | Sell |
|
|||||
|
2020
Q2 | $8.19M | Buy |
|
|||||
|
2020
Q1 | $371K | Hold |
|
|||||
|
2019
Q4 | $375K | Buy |
|
|||||
|
2019
Q3 | $104K | Hold |
|
|||||
|
2019
Q2 | $71K | Hold |
|
|||||
|
2019
Q1 | $47K | Buy |
|
|||||
|
2018
Q4 | $35K | Buy |
|
|||||
|
2018
Q3 | $77K | Buy |
|
|||||
|
2018
Q2 | $81K | Buy |
|
|||||
|
2018
Q1 | $91K | Sell |
|
|||||
|
2017
Q4 | $779K | Buy |
|
|||||
|
2017
Q3 | $301K | Buy |
|
|||||
|
2017
Q2 | $267K | Sell |
|
|||||
|
2017
Q1 | $435K | Buy |
|